Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPMorgan
Biotech
Why Nkarta's CEO wore head-to-toe pink at JPM—and why it matters
2025 was a year marked by profound uncertainty, driven in part by a federal crackdown on diversity, equity and inclusion measures.
Gabrielle Masson
Jan 20, 2026 4:25pm
JPM26: All of the meetings, none of the megadeals
Jan 15, 2026 4:30am
JPM26, Day 1: Updates from Lilly, Takeda, Novartis and Sofinnova
Jan 12, 2026 6:59pm
The JPM pregame: Jam-packed Jefferies conference makes its mark
Nov 19, 2024 11:00am
Renalytix aims for 2022 FDA clearance for kidney disease AI
Jan 13, 2022 12:46pm
JPM22, Day 4: Gritstone wants new biomarker; Galapagos' rebound
Jan 13, 2022 8:40am
